Agitation is a common and serious problem among people living with Alzheimer's dementia. Examples of some easily identifiable agitated behaviors are:
Restlessness, Pacing, Aimless wandering, Shouting, Screaming, Throwing things, Resistiveness, Constant requests for help, Tearing things up, Kicking, Hitting others or self, and/or not allowing others to help.
In this study, researchers want to find out if an investigational drug called AVP-786 is safe and effective in managing agitation in adults with Alzheimer's dementia, when compared to a placebo. Participants will be randomly assigned to receive either AVP-786 or a placebo.
Study duration:
Screening period up to 28-days
A 12-week Treatment Period
A 30-day Follow-up period at the end of the study.
There are 10 in-clinic study visits.